Autologous Melanoma Vaccine Induces Inflammatory Responses in Melanoma Metastases: Relevance to Immunologic Regression and Immunotherapy
Open Access
- 1 March 1993
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 100 (3) , S335-S341
- https://doi.org/10.1038/jid.1993.59
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Selective expansion of a specific anti‐tumor CD8+ cytotoxic T lymphocyte clone in the bulk culture of tumor‐infiltrating lymphocytes from a melanoma patient: Cytotoxic activity and T cell receptor gene rearrangementsEuropean Journal of Immunology, 1990
- Model Predicting Survival in Stage I Melanoma Based on Tumor ProgressionJNCI Journal of the National Cancer Institute, 1989
- Intercellular Adhesion Molecule Expression in the Evolving Human Cutaneous Delayed Hypersensitivity ReactionJournal of Investigative Dermatology, 1989
- Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma.The Journal of Experimental Medicine, 1989
- De novo expression of intercellular-adhesion molecule 1 in melanoma correlates with increased risk of metastasis.Proceedings of the National Academy of Sciences, 1989
- Active Immunotherapy of Human Melanoma Exploiting the Immunopotentiating Effects of CyclophosphamideCancer Investigation, 1988
- Human Tumor AntigensPublished by Elsevier ,1987
- HLA-DR histocompatibility leukocyte antigens permit cultured human melanoma cells from early but not advanced disease to stimulate autologous lymphocytes.Journal of Clinical Investigation, 1984
- Effect of Cyclophosphamide on Immunological Control MechanismsImmunological Reviews, 1982
- Enhancement of Dinitrochlorobenzene (DNCB) Contact Sensitization by Cyclophosphamide in the Guinea PigJournal of Investigative Dermatology, 1967